Other metabolic disease with epilepsy

"Other metabolic disease with epilepsy" (Orphanet code 225713) is a broad classificatory grouping used by Orphanet to categorize a heterogeneous collection of inborn errors of metabolism that present with epilepsy as a prominent clinical feature but do not fall neatly into more specific metabolic epilepsy categories. This grouping encompasses various rare metabolic conditions in which seizures arise as a consequence of disrupted biochemical pathways affecting the central nervous system. The underlying metabolic defects can involve amino acid metabolism, organic acid metabolism, energy metabolism, metal metabolism, vitamin-responsive disorders, and other biochemical pathways. Because this is a classification category rather than a single discrete disease entity, the specific clinical features, severity, age of onset, and affected body systems vary widely depending on the individual underlying metabolic disorder. Patients within this group typically present with recurrent seizures of various types (including generalized tonic-clonic, myoclonic, infantile spasms, or focal seizures), often accompanied by developmental delay or intellectual disability, and may have additional neurological features such as movement disorders, hypotonia, or regression of previously acquired skills. Other organ systems may also be involved depending on the specific metabolic defect, potentially including the liver, kidneys, eyes, heart, and skeletal system. Diagnosis generally requires a combination of clinical assessment, biochemical testing (blood and urine metabolic screening, cerebrospinal fluid analysis), neuroimaging, and genetic/molecular testing to identify the specific underlying metabolic disorder. Treatment approaches are highly variable and depend on the specific metabolic condition identified. Some disorders within this group are amenable to targeted metabolic therapies such as dietary modifications, vitamin or cofactor supplementation, substrate reduction therapy, or enzyme replacement therapy. Antiepileptic medications are used to manage seizures, though some metabolic epilepsies may be refractory to conventional anticonvulsants. Early diagnosis and initiation of appropriate metabolic treatment, when available, can significantly improve outcomes and seizure control in certain conditions within this group.

Common questions about Other metabolic disease with epilepsy